X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ANNALS OF ONCOLOGY

期刊標題檢索 ANN ONCOL 最新評論: Review speed: 3.0 | Submission hit rate: 25.0 Weighted research dire... (2023-07-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ANNALS OF ONCOLOGY]您好,您是該頁面的第 75440 位訪客。

期刊簡介
期刊名稱ANNALS OF ONCOLOGY ANNALS OF ONCOLOGY
LetPub Score
9.7
50 ratings
Rate

Reputation
10.0

Influence
9.5

Speed
9.7

期刊簡稱ANN ONCOL
ISSN0923-7534
E-ISSN1569-8041
h-index210
CiteScore
CiteScoreSJRSNIPCiteScore Rank
63.9013.9428.474
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q14 / 404
Category: Medicine
Subcategory: Hematology
Q12 / 137

自引率 (2023-2024)0.90%自引率趨勢
掲載範囲
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.
官方網站http://annonc.oxfordjournals.org/
在線稿件提交http://www.oxfordjournals.org/our_journals/annonc/for_authors/submission_online.html
開放訪問No
出版商Oxford University Press
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1990
每年文章數72每年文章數趨勢
黃金OA百分比88.05%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ14/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0923-7534%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Very fast, 2-3 Week(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【ANNALS OF ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS331002
    CANCER RESEARCH312134
    BMC CANCER245508
    Asian Pacific Journal of Cancer Prevention219229
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191631
    CLINICAL CANCER RESEARCH181667
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176425
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
  •  

    ANNALS OF ONCOLOGY ANNALS OF ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [ANNALS OF ONCOLOGY] 的評論撰寫評論
作者: 西域鹏云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-17 19:43:41 評論於
Review speed: 3.0 | Submission hit rate: 25.0 Weighted research direction: Tumor Experience Sharing: Why can't the homepage be opened now?
(0) 讚! | 西域鹏云

作者: 西域鹏云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-17 09:05:25 評論於
I can't open it either
(0) 讚! | 西域鹏云

作者: 紫霞盼之


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-07 22:55:01 評論於
Hello~ I would like to ask, does that include a systematic review?
(0) 讚! | 紫霞盼之

作者: 一二三四我是小雨点点


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2022-03-30 22:01:20 評論於
After submission, it took 2 days for the initial editor review, followed by 15 days under review. Then, it took another 2 days with the editor before finally being rejected without peer review.
(0) 讚! | 一二三四我是小雨点点

作者: 葵花辛巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-05 08:34:41 評論於
Is your under review with an external reviewer or with the editor?
(0) 讚! | 葵花辛巳

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:49:50 評論於
A comment is a type of research article published in a journal, generally a commentary or critique by experts in the field on specific hot topics or new research findings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:59:00 評論於
A letter is a type of research article published in a journal, typically shorter in length and with less research data
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 21:26:56 評論於
What is a letter?
(0) 讚! | 深渊兴业

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:17:34 評論於
What is a comment?
(0) 讚! | 深渊兴业

作者: 岚岚酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-02 16:01:19 評論於
Articles that do not accept pure basic research are all biased towards clinical research
(0) 讚! | 岚岚酱吖

作者: 明冠清妍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-06 21:09:09 評論於
Please translate the following passage into English and Japanese with the titles ":" and ":"
(0) 讚! | 明冠清妍

作者: Noah Holmes


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-06 12:15:46 評論於
Not necessarily submitted for review, it is also under review in the hands of the editor, and rejection usually takes about 1 week
(0) 讚! | Noah Holmes

作者: 藤原玄雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-29 14:41:56 評論於
When a submission has been under review for 10 hours, is it still with the editor or has it been sent to reviewers?
(0) 讚! | 藤原玄雅

作者: 藤原玄雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-29 08:56:18 評論於
After submitting my article, it went under review in just half a day. Is it in the hands of the editor or has it already been sent for review?
(0) 讚! | 藤原玄雅

作者: 是你的朗丽呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-18 19:43:15 評論於
Have you submitted your paper, senior? I am also working on a retrospective study
(0) 讚! | 是你的朗丽呀

作者: 日月康佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-18 09:51:28 評論於
Do you accept basic articles?
(0) 讚! | 日月康佳

作者: corrinezctzct


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2020-10-04 18:04:55 評論於
The review speed was very fast. The editor was very responsible, and really paid attention to clinical practical issues! Thumbs up! The article has been submitted and accepted directly.

(2) 讚! | corrinezctzct

作者: 紫霞元绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-14 08:35:06 評論於
OP, may I ask what does "under review" mean in your case?
(0) 讚! | 紫霞元绿

作者: 紫霞元绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-14 08:05:32 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as headers
(0) 讚! | 紫霞元绿

作者: 紫霞元绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-12 13:44:18 評論於
Just wondering, does "under review" mean it's been submitted for review?
(0) 讚! | 紫霞元绿

作者: 浩思可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-01 20:43:54 評論於
We do not accept unsolicited review articles, rejection email will be sent within two hours
(0) 讚! | 浩思可爱吗

作者: 蚀骨爱花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-27 13:14:03 評論於
Should be sent for external review, those that are not sent are usually rejected the next day
(0) 讚! | 蚀骨爱花

作者: 蚀骨爱花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-26 14:37:05 評論於
I would like to translate the following passage into English and Japanese, and title them as ":" and ":"
(0) 讚! | 蚀骨爱花

作者: 霹雳半亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-06 19:40:06 評論於
May I ask what is the current status of your submission?
(0) 讚! | 霹雳半亦

作者: 霹雳半亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-06 12:58:34 評論於
Request for specific submission status process
187****8818 No nickname 2020-01-08 Comment::Acceptance rate: about 25% Review time: about 1 month One article was rejected 7 days later without review. Another article was submitted on December 12th. Feedback received on January 8th. Currently undergoing minor revisions
(0) 讚! | 霹雳半亦

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [ANNALS OF ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*